Therapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Possible Use of Interferon on the Basis of Some Novel Concepts

Kazuma Ohyashiki The First Department of Internal Medicine, Tokyo Medical College, Tokyo, Japan

Junko H. Ohyashiki The First Department of Internal Medicine, Tokyo Medical College, Tokyo, Japan

Keisuke Toyama The First Department of Internal Medicine, Tokyo Medical College, Tokyo, Japan

Abstract

Current understanding of molecular genetics enables the establishment of new categories based on pathogenesis. Philadelphia (Ph) chromosome-positive leukemia has been reclassified into two molecularly distinct subsets, and the leukemogenesis at the cell level might be linked to the molecular changes. Therefore, treatment for leukemia patients with Ph chromosome could be based on the molecular characteristics. In this review, we discuss the strategy of treating patients with Ph-positive acute lymphoblastic leukemia and the benefit of the combined modality of interferon and chemotherapy.

Key Words:

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Therapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Possible Use of Interferon on the Basis of Some Novel Concepts

Information for

Open access

Opportunities

Help and information

Therapy for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Possible Use of Interferon on the Basis of Some Novel Concepts

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature